{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:43:40Z","timestamp":1793105020224,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.semradonc.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:28:07Z","timestamp":1757514487000},"page":"524-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimal Target Volume Delineation for Pancreatic Cancer: Triangulating What Should be Targeted"],"prefix":"10.1016","volume":"35","author":[{"given":"Amol","family":"Narang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.semradonc.2025.08.003_bib0001","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2025.08.003_bib0002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.6004\/jnccn.2018.7013","article-title":"Clinical impact of local progression in pancreatic cancer","volume":"16","author":"Cardillo","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0003","series-title":"Pancreatic Cancer","first-page":"1015","article-title":"New Japanese classification of pancreatic cancer","author":"Isaji","year":"2019"},{"issue":"1","key":"10.1016\/j.semradonc.2025.08.003_bib0004","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0b013e31823d813c","article-title":"Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer","volume":"255","author":"Takahashi","year":"2012","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.semradonc.2025.08.003_bib0005","first-page":"818","article-title":"Vascular invasion in pancreatic cancer: imaging modalities, preoperative diagnosis and surgical management","volume":"16","author":"Buchs","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1\u20132","key":"10.1016\/j.semradonc.2025.08.003_bib0006","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","article-title":"Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies","volume":"148","author":"Haeno","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semradonc.2025.08.003_bib0007","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2008.12.006","article-title":"Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma","volume":"35","author":"Van den Broeck","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.08.003_bib0008","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11605-008-0762-x","article-title":"Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio","volume":"13","author":"Asiyanbola","year":"2009","journal-title":"J Gastrointest Surg"},{"issue":"22","key":"10.1016\/j.semradonc.2025.08.003_bib0009","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1200\/JCO.2010.33.8038","article-title":"Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression","volume":"29","author":"Crane","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.08.003_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000337306","article-title":"Identification of the lymphatic drainage pathways from the pancreatic head guided by indocyanine green fluorescence imaging during pancreaticoduodenectomy","volume":"29","author":"Hirono","year":"2012","journal-title":"Dig Surg"},{"issue":"5","key":"10.1016\/j.semradonc.2025.08.003_bib0011","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.prro.2019.06.016","article-title":"Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline","volume":"9","author":"Palta","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.semradonc.2025.08.003_bib0012","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.semradonc.2025.08.003_bib0013","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0000000000001602","article-title":"Patterns of failure after neoadjuvant stereotactic body radiation therapy or fractionated chemoradiation in resectable and borderline resectable pancreatic cancer","volume":"49","author":"Barrord","year":"2020","journal-title":"Pancreas"},{"issue":"7","key":"10.1016\/j.semradonc.2025.08.003_bib0014","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/cam4.4527","article-title":"High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapy","volume":"11","author":"Hill","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02924114","article-title":"Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer","volume":"10","author":"Nagakawa","year":"1991","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0016","first-page":"51","article-title":"Clinicopathologic study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer","volume":"39","author":"Nagakawa","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.mpa.0000194607.16982.d7","article-title":"Distribution of lymphatic vessels in the neural plexuses surrounding the superior mesenteric artery","volume":"32","author":"Jin","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0018","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4","article-title":"Perineural invasion by ductal adenocarcinoma of the pancreas","volume":"65","author":"Takahashi","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00006676-199605000-00006","article-title":"Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer","volume":"12","author":"Nakao","year":"1996","journal-title":"Pancreas"},{"key":"10.1016\/j.semradonc.2025.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318065bfe6","article-title":"Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact","volume":"31","author":"Mitsunaga","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.semradonc.2025.08.003_bib0021","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jhbp.402","article-title":"Mesopancreas is a misnomer: time to correct the nomenclature","volume":"23","author":"Sharma","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"10.1016\/j.semradonc.2025.08.003_bib0022","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejso.2011.12.015","article-title":"Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors","volume":"38","author":"Adham","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.semradonc.2025.08.003_bib0023","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.hpb.2017.07.007","article-title":"The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study","volume":"19","author":"Hackert","year":"2017","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.semradonc.2025.08.003_bib0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.prro.2022.01.005","article-title":"Location, Location, Location: what should be targeted beyond gross disease for localized pancreatic ductal adenocarcinoma? Proposal of a standardized clinical target volume for pancreatic ductal adenocarcinoma of the head: the \u201cTriangle Volume.\u201d","volume":"12","author":"Hill","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.semradonc.2025.08.003_bib0025","article-title":"Patterns of failure in patients with borderline resectable\/locally advanced pancreatic cancer after preoperative chemotherapy and stereotactic body radiation therapy","volume":"9","author":"Chung","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.08.003_bib0026","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ijrobp.2023.06.230","article-title":"Utilization of the triangle volume in patients with localized PDAC undergoing pre-operative SBRT: report of early outcomes","volume":"117","author":"Mao","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.semradonc.2025.08.003_bib0027","article-title":"A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic adenocarcinoma: study protocol of a phase I trial","volume":"173","author":"Reddy","year":"2022","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.08.003_bib0028","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2024.10.026","article-title":"NRG oncology international consensus contouring atlas on target volumes and dosing strategies for dose-escalated pancreatic cancer radiation therapy","volume":"121","author":"Sanford","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:10:57Z","timestamp":1760227857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429625000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1053429625000670"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.08.003","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Target Volume Delineation for Pancreatic Cancer: Triangulating What Should be Targeted","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}